<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Flaig Discusses NCCN Guidelines in Bladder Cancer

Written by Targeted Oncology on January 24, 2023

Thomas Flaig, MD, vice chancellor of research for CU Denver and CU Cancer Center member, discusses some of the current NCCN guidelines in bladder cancer.

Topics: Press Coverage

Comments

Related Stories